Further $7m to back cardiac arrhythmia co
This article was originally published in Clinica
Rhythmia Medical has closed a $7m series B financing led by Norwich Ventures. Other participants in the round include unnamed "medical device industry leaders" as well as previous investors in Woburn, Massachusetts-based startup. The proceeds will be used to accelerate its R&D activities and expand its workforce. Rhythmia is developing a minimally-invasive medical device for treating cardiac arrhythmia. It expects to initiate animal studies within 18-24 months.